Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Valtecne S.p.A. is a company engaged in precision engineering and manufacturing, primarily focused on producing high-quality mechanical components. The company serves a variety of industrial sectors, including aerospace, energy, and medical devices. Valtecne S.p.A. is known for its state-of-the-art manufacturing facilities that leverage cutting-edge technologies like CNC machining, ensuring precise and reliable production processes. In the aerospace sector, Valtecne S.p.A. provides components that meet stringent quality and safety standards, contributing to the manufacturing of aircraft systems. In the energy industry, the company supplies parts essential for the operation of wind turbines and other renewable energy systems, supporting global energy transition efforts. In the medical field, Valtecne S.p.A. produces critical components for medical devices, adhering to rigorous industry regulations. Valtecne S.p.A.'s impact on these sectors underscores its importance as a reliable partner in the supply chain, with a focus on innovation and quality. As a publicly traded company, it epitomizes industrial prowess and contributes to advancements in precision engineering across various high-tech industries.
€7.95
+€0.05 (+0.63%)
EOD Jun 23, 2026 · Twelve Data
16.07% operating margin is respectable but not wide. ROIC at 11.88%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 1.1% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 57% versus the prior year, cash generation momentum has weakened.
13.7x earnings, 26.1x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€31M
▼ -1.1% YoY
Net Income (TTM)
€4M
▲ +3.9% YoY
Op. Margin
16.07%
▲ +0.5pp YoY
ROIC
11.88%
▼ -1.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€2M
▼ -57.0% YoY
Op. Cash Flow (TTM)
€3M
▼ -52.0% YoY
Net Debt
-€1M
Net Cash Position
Cash & Equiv.
€11M
3Y CAGR: +9.4%
Continue Research